SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

AstraZeneca Pharma India informs about standalone financial results

03 Feb 2017 Evaluate

AstraZeneca Pharma India has informed about Standalone Financial Results & Limited Review for the period ended December 31, 2016.

The above information is a part of company’s filings submitted to BSE.

Astrazeneca Pharma Share Price

8500.20 -3.10 (-0.04%)
24-Jun-2026 11:11 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1866.25
Dr. Reddys Labs. 1333.90
Cipla 1429.65
Zydus Lifesciences 1106.70
Lupin 2374.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: